A. Nye

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

R. Fuller, R. Buchanan, L. Hong, 2011, Archives of general psychiatry.